FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

Here's who could be helped by new cancer drug — and when

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial - The Lancet Oncology

Shubham Pant MD Anderson Cancer Center

Coverage Analysis - Clinical Trials/Research (Setup) - Set Up - UTHealth Houston

New Survey Reveals Cancer Survivors' Attitudes to Care, Unmet Needs, Article

Feeling Like Death': Inside a Houston Hospital Bracing for a Virus Peak - The New York Times

Harnessing the Immune System to Fight Cancer - The New York Times

Ashish M. Kamat MD Anderson Cancer Center

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation

New Drugs for Ovarian Cancer Patients - WSJ

Stephen Hahn - Wikipedia

FDA clears MD Anderson to test skin cancer treatment on humans

Drug factory' implants eliminate ovarian, colorectal cancer in mice, Rice News, News and Media Relations

At the Bedside: Pancreatic cancer patient 'back on track' after UTHealth Houston clinical trial therapy shrinks tumor - UTHealth Houston

Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week